Lisa Lacasse shared insights on Cancer Survivorship Summit and its agenda
Lisa Lacasse, the President of the American Cancer Society Cancer Action Network (ACS CAN), shared on LinkedIn:
“American Cancer Society Cancer Action Network (ACS CAN) is proud to be part of this Cancer Survivorship Summit that addresses life after diagnosis with breast cancer survivor U.S. Representative Debbie Wasserman Schultz. The Summit highlights gaps in survivorship care, discuss policy proposals, and provide national and Florida community-based resources and support services. This gathering brings together survivors, caregivers, and healthcare professionals to share stories, support one another, and learn about the latest advancements in cancer survivorship.
Our very own Director Director of Federal Relations, Access to Care Jelani Murrain will be facilitating a panel discussion on health disparities, a topic at the center of our work at ACS CAN. This segment will highlight social determinants of health and their impact on survivors, such as transportation, childcare, housing, homecare, food insecurity, access to broadband, and more. It will highlight health disparities and equity issues that affect certain communities and how this creates barriers to survivorship care.
Panelists will include:
Michelle Clark, Nova Southeastern University
Usha Menon, University of South Florida
Gary Puckrein, National Minority Quality Forum (NMQF)
Farhad Islami, American Cancer Society (ACS)
My friend, Arif Kamal will also participate in the panel Survive and Thrive: Navigating Survivorship with other brilliant navigation experts.
Excited to continue to hear from guests from The White House, the American Association for Cancer Research, the American Society for Reproductive Research, Child Cancer Cause, Moffitt Cancer Center, UM Sylvester Comprehensive Cancer Center, Tigerlily Foundation, Young Survival Coalition, and Cancer Cause.
Join me in watching.”
For more details click here.
Source: Lisa Lacasse/LinkedIn
-
12:46 30/11/23 | BlogJohanna Joyce: the Flashlight method
-
12:31 30/11/23 | InsightJeff Ryckman: Omitting RT in bulky early-stage cHL
-
07:45 30/11/23 | BlogAaron Goodman: Hemoglobin Dissociation Curve! Good stuff
-
12:31 30/11Jeff Ryckman: Omitting RT in bulky early-stage cHL
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows